Trial intelligence / Profile preview

Prevnar vs Pneumovax in Bone Marrow Transplant Donors and Recipients

NCT00143780Phase 4Completed

Sponsor
University Health Network
Start
May 2002
Primary completion
Jul 2006
Modality
Split/Subunit Vaccines
Countries
1
01

Overview

Phase 4, randomised trial of pneumococcal 7-valent conjugate vaccine in pneumococcal infection (2 arms), sponsored by University Health Network. Primary endpoint: Immunogenicity of two vaccines via serotype specific capsular antibody formation and functional antibody formation. Started May 2002; status: completed.

02

Drugs

pneumococcal 7-valent conjugate vaccine
03

Conditions

pneumococcal infection

Beyond the preview

Go deeper on NCT00143780.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00143780.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call